Frontlight ResearchEarly access
Trial site
Affiliated Cancer Hospital of Chongqing University
- 2running trials
- 3closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Metastatic breast cancer1 trial
- Ovarian cancer1 trial
- Phase
- Phase 1/22 trials
- Phase 32 trials
- Phase 2/31 trial
- Status
- Active, not recruiting1 trial
- Completed1 trial
- Recruiting1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Adlai Nortye Biopharma Co., Ltd.1 trial
- Bio-Thera Solutions1 trial
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- Innovent Biologics (Suzhou) Co. Ltd.1 trial
- Sellas Life Sciences Group1 trial
Running trials
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer1 recruiting
Closed trials
Terminated
Recruiting
Completed
The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC
Site data: ClinicalTrials.govUpdated 12 Nov 2026